A new randomized, double-blind, placebo-controlled study has found that a combination of nootropic supplements is worse than caffeine at improving cognitive performance.
“We were interested in researching this topic to find out if we can provide scientific evidence for the claimed nootropic effects of CAF+. In other words, to see if CAF+ is indeed able to improve memory and/or other cognitive functions in young and healthy people,” said study author Stéphanie Caldenhove of Maastricht University.
CAF+ contains 100 mg caffeine, 200 mg l-theanine, 40 mg vinpocetine, 300 mg l-tyrosine, 1 mg vitamin B12, and 20 mg vitamin B6.
This article highlights the scope for developing therapeutics with new innovative, alternative approaches. The current trillion dollars pharmaceutical industry is in peril where the current drug development pipeline is slow, inefficient and incapable of being extended to multi-combination drug therapies as well as minimally focused on prevention. The complex modeling of diseases and biological functions has been limited because of the inability to integrate large scale molecular pathways.
Watch this Video to understand how recent advances provide breakthrough technology for doing scalable modeling of complex molecular systems to dramatically accelerate drug discovery and development.